Dr. Anjali Vaidya Discusses Findings from New Pulmonary Arterial Hypertension Study with AJMCTV

AJMC reported on a study co-authored by Anjali Vaidya, MD, FACC, FASE, FACP, Co-Director of the Pulmonary Hypertension, Right Heart Failure & Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program at Temple University Hospital, that was presented at the ATS conference. Dr. Vaidya and colleagues found critical care gaps for patients with methamphetamine-associated pulmonary arterial hypertension (PAH), emphasizing the need for early diagnosis and integrated support.